Transforming Reproductive Medicine Worldwide Conference 2013

Transforming Reproductive
Medicine Worldwide
Continuing Education Material
DAILY SCHEDULE • POSTGRADUATE COURSES • PLENARY SESSIONS
TRILOGIES • SYMPOSIA • INTERACTIVE SESSIONS • VIDEO SESSIONS
OCTOBER 12 - 17, 2013

Participate
in
the
IFFS/ASRM
2013
Twitter
Wall!
During
the
IFFS/ASRM
2013
Annual
Meeting,
all
participants
are
invited
to
post
opinions,
reports,
and
feedback
on
the
meeting’s
Twitter
Wall.
The
Twitter
Wall
can
be
viewed
at
the
Convention
Center’s
Main
Lobby.
All
you
need
is
a
mobile
device
with
an
installed
Twitter
app,
or
a
web
browser.
Setting
Up
A
Twitter
Account
Go
to
www.twitter.com,
and
sign
up.
You
will
need
to
enter
identifying
information
and
agree
to
the
terms
of
service.
You
will
need
to
verify
your
email
address
before
continuing.
Twitter
will
walk
you
through
a
setup
wizard
of
sorts,
and
ask
you
to
follow
five
or
more
people.
This
is
optional,
though
the
website
doesn’t
give
you
an
option
to
skip
it.
Search
for
“#IFFSASRM”
if
you
wish
to
follow
the
messages
at
the
conference,
and
search
for
“@ReprodMed”
if
you
also
wish
to
follow
ASRM’s
Twitter
feed.
Otherwise,
at
this
point,
if
you
don’t
want
to
go
any
further
in
the
setup
wizard,
go
back
to
www.twitter.com
and
independently
update
your
profile
page
and
if
desired,
add
a
photo.
Other
Twitter
users
like
to
see
photos
of
tweeters.
Install
a
Twitter
Application
on
your
Mobile
Device
One
option
for
using
Twitter
is
to
install
a
Twitter
app
on
your
mobile
device.
Go
to
https://twitter.com/download
and
select
your
device.
If
you
do
not
wish
to
install
an
app
for
Twitter,
you
can
still
use
Twitter
within
your
web
browser.
Sending
a
Tweet
to
the
IFFS/ASRM
2013
Twitter
Wall
You
can
do
this
within
the
Twitter
app
on
your
mobile
device,
or
on
the
Twitter
website.
On
the
website,
you
can
post
a
tweet
by
clicking
on
Home
and
then
type
inside
the
left-‐hand
box
that
says
“Compose
new
Tweet”.
You
are
limited
to
140
characters
in
a
single
tweet.
At
the
end
of
each
message,
in
order
for
your
message
to
appear
on
the
Twitter
wall,
you
must
put
#IFFSASRM
at
the
end,
such
as:
Watching
a
grt
pres.
on
endometriosis
by
Dr.
Jones.
Fantastic
new
data
w/2000
pts!
#IFFSASRM
Plenary
Speaker
Dr.
Jones
starting
now
–
hall
packed,
exciting,
standing
rm
only!
#IFFSASRM
or
Twitter
Etiquette
All
incoming
tweets
are
monitored
by
ASRM
staff,
and
those
tweets
that
show
up
with
the
hashtag
#IFFSASRM
and
that
pass
moderation
will
be
posted
to
the
Twitter
Wall.
In
order
for
a
tweet
to
pass
moderation,
the
following
guidelines
should
be
kept
in
mind:
• Messages
must
be
about
Meeting
content
or
activities.
• Messages
cannot
contain
personal
information.
• Messages
cannot
personally
attack
another
person.
• Messages
that
ASRM
considers
unprofessional
will
not
be
displayed
on
the
Twitter
Wall.
We
hope
you’ll
join
us
in
tweeting
the
#IFFS/ASRM
Meeting
in
October!

Welcome to Boston!
Boston is more vibrant than ever! New green spaces are sprouting up all over, and a revitalized waterfront has added to the city’s
already dynamic downtown neighborhoods. These developments are thanks in part to the city’s Big Dig project, which is now
complete. Additionally, Logan International Airport’s recent upgrades are making it easier than ever to get in and out of the city, and
new sights and attractions are providing more for everyone to see and do while in Boston.
Boston’s Waterfront has become an idyllic setting for watching sailboats and ferries glide in and out of the harbor and an excellent
destination for classic New England seafood restaurants.
Boston’s Rose Kennedy Greenway consists of three parks and a total of 30 acres of beautiful, tree-lined corridors. Visitors will find
more than 900 trees, public art, fountains and great places for exercise or contemplation. In the works for the Greenway are the Boston
Museum Project, which will focus on the last 200 years of Boston history, and The New Center for Arts and Culture, which will
present a variety of dance performances, films, music, lectures and art.
The new 44-mile Boston HarborWalk includes the downtown Boston waterfront and continues north and south along wharves, piers,
museums, historic forts, bridges, beaches and shoreline from Chelsea Creek to the Neponset River. The HarborWalk also connects to
new and existing trails: The Freedom Trail, the new Walk To The Sea, the Emerald Necklace, the Charles River Esplanade, the Rose
Kennedy Greenway, and in the future, the South Bay Harbor Trail.
The one-mile Walk To The Sea is a Beacon Hill-to-the-waterfront marked walkway. Beginning at the Massachusetts State House, the
visitor learns about the four centuries of maritime history from Beacon Hill to State Street to the 18th century Long Wharf.
Constructed from dirt excavated from the Big Dig’s extensive network of tunnels, Spectacle Island in Boston Harbor features a
marina, visitor center, sandy beaches and five miles of walking trails that lead to the crest of a 157-foot hill offering panoramic views
of the harbor and the city. Visitors are welcome from dawn to dusk during the summer months. Passenger ferry service is available
from Boston.
Chinatown Park, a beautiful parcel of land in Chinatown, is populated by bamboo trees, azaleas, stones and a peaceful stream. The
new park is situated at the south end of the Greenway and is the perfect place to experience the Chinese ideal of Feng Shui, followed
by an authentic dim sum meal.
History around every corner, and so much more! Boston’s rich art, music and dance institutions, theatre and cultural attractions,
distinguished dining and nightlife venues, world-class shopping and championship sports teams make it a unique place for travelers to
visit. The city’s downtown neighborhoods offer endless unique experiences and its proximity to other must-see sites all around New
England make it one of the country’s most diverse and exciting locales.
Here in Boston, visitors are never at a loss for things to do. The many museums, concert halls, theaters and nightclubs are always
showcasing great talent and events. There’s the internationally acclaimed Museum of Fine Arts, the Museum of Science, New England
Aquarium and the John F. Kennedy Presidential Library & Museum. Beyond the museum scene, there’s the world-famous Boston
Symphony Orchestra and Boston Pops, local and pre-Broadway theater, distinctive dining, endless opportunities for shopping and
sightseeing, and a year-round calendar of special events and celebrations.
Boston is home to a grand tradition of sporting excellence. This is where storied franchises such as the Red Sox (2004 and 2007
World Series Champions), the Celtics (2008 World Champions), the Bruins, and the New England Patriots (2001, 2003 and 2004
Super Bowl Champions) all play their games. Visiting sports fans can’t help getting caught up in the enthusiasm.
In addition to everything within the city limits, some of Massachusetts’ most scenic and historic towns are just a short distance from
the city center. There are sights to see at every turn. Cambridge is often referred to as “Boston’s Left Bank” with an atmosphere —
and attitude — all its own. It’s the spirited, slightly mischievous side of Boston, just a bridge away on the other side of the Charles
River. Packed with youthful vitality and international flair, it’s a city where Old World meets New Age in a mesmerizing blend of
history and technology. As the East Coast’s leading hub for high tech and biotech, Cambridge has a creative, entrepreneurial spirit. It
is also the birthplace of higher education in America. Harvard College was founded in 1636, and across town, Massachusetts Institute
of Technology (MIT) is known as the epicenter of cyberculture. Both universities house renowned museum collections and tours
that are open to the public. As a captivating, offbeat alternative to Boston’s urban center, the “squares” of Cambridge are charming
neighborhoods rich in eclectic shopping, theaters, museums and historic sites. Cambridge also offers a tantalizing array of dining
options for the visitor with a sophisticated palate.
Information on Boston provided by the Greater Boston Convention and Visitors Bureau
3

museum-ad.indd 2 8/29/13 1:53 PM

NIGHTATMUSEUM
THE
OF SCIENCE
BOSTON • MA
Party at Boston’s Museum of Science:
THREE FLOORS TO EXPLORE
THE RED, GREEN AND BLUE WINGS OPEN TO YOU
INCLUDES: THEATER OF ELECTRICITY • MUGAR OMNI
THEATER (IMAX) • SOUNDSTAIR • BUTTERFLY GARDEN •
CHARLES HAYDEN PLANETARIUM • AND MUCH MORE
WEDNESDAY, OCTOBER 16, 2013
7:00 PM - 10:00 PM • TICKETS $100
Food provided by Wolfgang Puck Catering
Beer, Wine & a Specialty Drink • 3-D Movie
Music and Live DJ • Interactive Activities
PLUS Transportation to/from ASRM hotels

Shuttle Bus Routes
Route # 1
HOTELS PICK UP LOCATION
Sheraton Boston Curbside on Dalton St.
Route # 2
Westin Copley Walking to Marriott (Curbside on Huntington)
Fairmont Copley Walking to Marriott (Curbside on Huntington)
Boston Marriott Copley Place Curbside on Huntington
Route # 3
Hilton Financial Main Entrance
Omni Parker House Curbside on Tremont, across St. next to bank
Hyatt Regency Curbside on Avenue de Lafayette
Route # 4
Boston Park Plaza Columbus Ave. Entrance
Courtyard Tremont Tremont St. Entrance
Route # 5
Renaissance Waterfront Side Entrance on Congress
Seaport Boston Plaza Level of Hotel
Walking Hotel
Westin Boston Waterfront No Shuttle Service Provided

Shuttle Bus Schedule
DATE SERVICE HOURS FREQUENCY
Saturday, October 12, 2013 6:30am-9:30am
4:30pm-6:30pm
30 MINUTE SERVICE
30 MINUTE SERVICE
Sunday, October 13, 2013 6:30am-9:30am
4:30pm-10:30pm
30 MINUTE SERVICE
30 MINUTE SERVICE
Monday, October 14, 2013
6:30am-9:30am
9:30am-3:30pm
3:30pm-7:30am
15 MINUTE SERVICE
30 MINUTE SERVICE
15 MINUTE SERVICE
Tuesday, October 15, 2013
6:30am-9:30am
9:30am-3:30pm
3:30pm-7:30am
15 MINUTE SERVICE
30 MINUTE SERVICE
15 MINUTE SERVICE
Wednesday, October 16, 2013
6:30am-9:30am
9:30am-3:30pm
**3:30pm-10:30pm**
15 MINUTE SERVICE
30 MINUTE SERVICE
15 MINUTE SERVICE
Thursday, October 17, 2013 6:30am-9:30am
9:30am-3:30pm
15 MINUTE SERVICE
30 MINUTE SERVICE
**Wednesday, October 16, 2013: Shuttle Service will run from the HOTELS to the MUSEUM OF
SCIENCE from 6:45pm-10:30pm EVERY 15 Minutes**

Reception will be held in the Boston Convention and Exhibition Center's Exhibit Hall following the Opening Ceremony.

Write the Next Chapter
Sustaining education, research, and advocacy programs for the future
The American Society for Reproductive Medicine has had a long and distinguished history, contributing
to reproductive medicine for more than 69 years. Please join us to ensure our continued excellence in
education, research and advocacy by supporting the ASRM Fund Development Program.
Ways to be a Champion
Donate to support these programs:
Education
• SMRU Traveling Scholar
• Contraception Lecturer
• Menopause Lecturer
• Resident Reporter Program
• ASRM Fellows Retreat
• Resident Education through ASRM eLearn®
Research
• ASRM Distinguished Researcher Award
• Trainee Travel Fund
• CREST Program
Advocacy
• J. Benjamin Younger Offi ce of Public Affairs
• Reproduction and Public Policy Fellowship
in the J. Benjamin Younger Offi ce of Public
Affairs
Other Programs
• Memorial and Special Occasion Giving
• Planned Giving
• Bequests
• Charitable Remainder Trusts
• Life Insurance
For more information about these programs, please contact Pam Nagel,
ASRM Director of Society Advancement, at 205-978-5000, ext. 121 or pnagel@asrm.org.
JOINT MEETING WITH IFFS/ASRM • OCT. 12-17, 2012 • BOSTON, MA. ASRM MEMBER GUIDE - 7

IFFS WELCOME
As President of the International Federation of Fertility Societies (IFFS), I am delighted that our organization
is holding its triennial meeting conjointly with ASRM in Boston, October 12-17, 2013. The first triennial IFFS
congress was held in 1953 in New York City and since then has returned to the United States on two occasions.
The last conjoint meeting was in 1998 (San Francisco), at that time the largest aggregation of reproductive
medicine specialists and scientists ever assembled. The San Francisco meeting leveraged the IFFS toward
its now vigorous efforts that include workshops conducted throughout the developing world, active public
relations, guidelines for topics requiring international interaction (e.g., cross border care), and online resources.
A regional IFFS international meeting is held in years during which the IFFS Triennial Congress is not held. In
2014, we will be meeting in Yokahama, Japan, conjointly with the Japanese Fertility Society.
Given the many international participants who regularly attend ASRM as well as IFFS, the IFFS/ASRM
program will be familiar in format. ASRM staples remain, and IFFS strives to be complementary. The IFFS
Joe Leigh Simpson, M.D.
IFFS President 2012-2016
mission is to stimulate basic and clinical research, disseminate education, and encourage superior clinical care of patients in infertility
and reproductive medicine worldwide. Our national member societies, which now number 54 including ASRM, help carry this out.
IFFS/ASRM 2013 thus offers postgraduate programs of international focus, talks by colleagues from all geographic regions, and topics
covered that are not typical for ASRM. A special feature is the presentation of the IFFS Surveillance Report on Assisted Reproductive
Technologies, a triennial compilation and synthesis providing information on ART that began in 1998. The IFFS scientific program
is robust throughout. Distinct from ASRM are the IFFS trilogies. Three talks per session on a single topic by three different experts
who focus on their forté – basic science, translating discoveries into clinical application, or integrating recent knowledge into clinical
management. The IFFS Scientific Committee, composed of elected representatives from nine member societies, worked assiduously
with Professor Basil Tarlatzis and the ASRM Scientific Program team.
IFFS is grateful to ASRM for hosting this Congress, using its good offices, and providing IFFS access to its exemplary staff. As a
Past ASRM President myself, I truly appreciate the inconvenience that such an “out of sync” meeting entails. Yet IFFS is confident
that this conjoint meeting will underscore the old adage that the product should be greater than the sum of the individual parts. On a
personal note, I look forward to seeing colleagues in Boston and enjoying a delightful social program - the Museum of Science on
Wednesday night is a “can’t miss” event. And, of course, I shall enjoy coming away with the best science that reproductive medicine
offers.
Sincerely,
Joe Leigh Simpson, M.D.
IFFS President 2012-2016
ASRM WELCOME
As President of the American Society for Reproductive Medicine, I enthusiastically welcome you to the 69th
Annual Meeting of the ASRM conjoint with the 21st Meeting of the International Federation of Fertility
Societies (IFFS) in Boston, Massachusetts, October 12-17, 2013. Serdar Bulun and the ASRM Scientific
Program Committee, along with Basil Tarlatzis and the IFFS Scientific Committee, have put together a
phenomenal program, along with Anuja Dokras for the Postgraduate Program and Steven Palter for the Video
Program.
As a conjoint meeting, we have extended the program by one day to accommodate additional interactive
poster sessions, the traditional IFFS trilogies, and regional meetings for our international societies. The theme
of our conjoint meeting is “Transforming Reproductive Medicine Worldwide,” and we have planned plenary
lectures by international luminaries addressing state-of-the-art issues in reproductive medicine and science.
We shall continue to have roundtables, videos, interactive sessions, symposia, and the popular sessions focused
Linda C. Giudice, M.D., Ph.D.
ASRM President 2012-2013
on menopause and contraception. During the 2013 meeting, we also plan hands-on robotic and other surgical intensives, and to focus
more broadly on global applications of infertility therapies and reproductive health in low resource settings.
As a conjoint meeting, our U.S. and international members will join the membership of the IFFS in reaching out to specialists in
reproductive medicine worldwide to learn from each other about issues that are unique in different parts of the world and those that are
common to us all. This conjoint meeting provides an opportunity to learn the latest research in the oral and poster presentations and
other venues. Our many special interest and professional groups within ASRM will be presenting data that can be considered by all.
The conjoint meeting of the IFFS/ASRM in Boston 2013 will provide an opportunity to learn, to see old friends, meet new friends,
and see the world of reproductive medicine through a new lens. We are developing a social program for all in Boston, a vibrant city
with great historical significance in the U.S. and globally. I look forward to seeing you in Boston in 2013, as we all participate in the
process of “Transforming Reproductive Medicine Worldwide!”
Sincerely,
Linda C. Giudice, M.D., Ph.D.
ASRM President 2012-2013

INSIDE Be Sure to Visit the Exhibit Hall
IFFS WELCOME . . . . . . . . . . . . . . . . . . . . . 8
ASRM WELCOME . . . . . . . . . . . . . . . . . . 8
EXHIBIT HOURS . . . . . . . . . . . . . . . . . . . . . 9
IFFS/ASRM CONJOINT
MEETING PROGRAM
PLANNING COMMITTEE . . . . . . . . . . . 10
IFFS OFFICERS & BOARD OF
DIRECTORS . . . . . . . . . . . . . . . . . . . . . . . 11
ASRM OFFICERS & BOARD OF
DIRECTORS . . . . . . . . . . . . . . . . . . . . . . . 11
IFFS/ASRM ANNUAL MEETING
POLICIES & DISCLAIMERS . . . . . . . . . 12
CONTINUING
EDUCATION CREDIT . . . . . . . . . . . . . 13
DISCLOSURE STATEMENTS &
CONFLICT OF INTEREST POLICY . . . . 14
POSTGRADUATE
PROGRAM . . . . . . . . . . . . . . . . . . 15-34
NEEDS ASSESSMENT &
LEARNING OBJECTIVES . . . . . . . . . . . 35
SCIENTIFIC PROGRAM
DAILY SCHEDULE . . . . . . . . . . . . . 36-47
NICHD DETERMINANTS OF
GAMETE & EMBRYO QUALITY
SYMPOSIUM . . . . . . . . . . . . . . . . . . . . 48
MENOPAUSE DAY . . . . . . . . . . . . . . . 19
SURGERY DAY . . . . . . . . . . . . . . . . . 50-51
CONTRACEPTION DAY . . . . . . . . . . . 52
ENDOCRINE DISRUPTORS
& REPRODUCTIVE HEALTH
ACROSS THE LIFESPAN PANEL
PRESENTATION . . . . . . . . . . . . . . . . . . 53
EDUCATIONAL SUPPORTERS . . . . . . . 54
PLENARY SESSIONS . . . . . . . . . . . . 55-60
TRILOGIES . . . . . . . . . . . . . . . . . . . 61-65
ASRM SYMPOSIA . . . . . . . . . . . . 66-88
INTERACTIVE SESSIONS . . . . . . . 89-101
ASRM VIDEO SESSIONS . . . . . . 102-108
AAGL FILM FESTIVAL
VIDEO SESSION . . . . . . . . . . . . . . . . 109
PARTICIPANT & SPOUSE/PARTNER
DISCLOSURES INDEX . . . . . . . . 110-112
VIDEO DISCLOSURES INDEX . . . . . . 113
PROGRAM PARTICIPANTS -
NON-ORAL/POSTER PRESENTERS
INDEX . . . . . . . . . . . . . . . . . . . . 114-116
Sunday, October 13 . . . . . . . . . 7:30 p.m. - 9:30 p.m.
Monday, October 14 . . . . . . . . . 9:00 a.m. - 5:00 p.m.
Tuesday, October 15 . . . . . . . . . 9:00 a.m. - 5:00 p.m.
Wednesday, October 16 . . . . . . 9:00 a.m. - 5:00 p.m.
For the safety of your child and in order to
maintain the scientific nature of the display,
no children under the age of 16 (except infants
under 6 months of age carried in arms at all times)
will be allowed in the Exhibit Hall.
Strollers and infants in backpacks are not permitted
in the Exhibit Hall or Poster Hall at anytime.
CERTIFICATE OF ATTENDANCE
Proof of attendance is available on request from J. Spargo at the
registration desk. Continuing Education Credit information is located in the
front of the Postgraduate Course syllabi, in the Final Program and online.
ADMISSION BADGES
Name badges will be issued for the Postgraduate and Scientific Programs
and are required for admission. Spouse/guest badges will be issued and
are required for admission to spouse/guest activities and the Exhibit Hall.
PHOTO/AUDIO/VIDEO RECORDING
Photographing or audio/video recording of any session for personal or
commercial purposes without permission is prohibited.
Morning Poster Sessions
Poster Sessions will be held on Tuesday, Wednesday,
and Thursday mornings from 7:00 a.m. until 8:45 a.m.
Complimentary continental breakfast will be available.
No reservations are required.

IFFS/ASRM CONJOINT MEETING
PROGRAM PLANNING COMMITTEE
IFFS SCIENTIFIC COMMITTEE
Basil Tarlatzis (Greece), Chair
Joe Leigh Simpson (USA), President
Liselotte Mettler (Germany), 2010 Chair Local SC
Linda Giudice (USA), 2013 Congress Chair
Serdar Bulun (USA), 2013 Chair Local SC
Dhiraj Gada (India), 2016 Congress Chair
Narendra Malhotra (India), 2016 Chair Local SC
Richard Kennedy (UK), Secretary General, ex officio member
Paul Devroey (Belgium), Director of Medical Education, ex officio member
David Healy, IFFS President 2010-2012
IFFS SCIENTIFIC COMMITTEE MEMBER SOCIETIES
Brazilian Society of Human Reproduction Artur Dzik
British Fertility Society Sue Avery
Finnish Gynecological Association Antti Perheentupa
Japan Society of Reproductive Medicine Minoru Irahara
Fertility Society of Australia Cynthia Farquhar
Korean Society for Reproductive Medicine Seok Hyun Kim
American Society for Reproductive Medicine Alan DeCherney (ex officio)
American Society for Reproductive Medicine Andrew La Barbera (ex officio)
American Society for Reproductive Medicine Robert Rebar (ex officio)
ASRM SCIENTIFIC AND POSTGRADUATE PLANNING COMMITTEES
Linda C. Giudice, M.D., Ph.D., ASRM President
Serdar E. Bulun, M.D., Scientific Program Chair
Lawrence C. Layman, M.D., Interactive Sessions Chair
Kurt T. Barnhart, M.D., Roundtable Program Chair
Anuja Dokras, M.D., Ph.D., Postgraduate Program Chair
Lisa M. Halvorson, M.D., Postgraduate Program Co-Chair
Kathleen Hwang, M.D., Postgraduate Program Coordinating Chair
Bradley J. Van Voorhis, M.D., Postgraduate Program Ad Hoc Member
G. David Ball, Ph.D., and Charles Coddington, III, M.D., Society for Assisted Reproductive Technology Program Chairs
Kurt T. Barnhart, M.D., and James Segars, M.D., Society for Reproductive Endocrinology and Infertility Program Chairs
Paul J. Turek, M.D., and Ajay Nangia, M.D., Society for Male Reproduction and Urology Program Chairs
Grace M. Janik, M.D., and Jeffrey M. Goldberg, M.D., Society of Reproductive Surgeons Program Chairs
Nidhi Desai, J.D., Legal Professional Group Program Chair
Claudia Pascale, Ph.D., and Alice D.Domar, Ph.D., Mental Health Professional Group Program Chairs
Deborah L. Jaffe, B.S.N., Nurses’ Professional Group Program Chair
Thomas G. Turner, M.S., and Charles L. Bormann, Ph.D. Society of Reproductive Biologists and Technologists Program
Chairs
Joseph J. Travia, Jr., B.S., M.B.A., Association of Reproductive Managers Program Chair
Catherine Racowsky, Ph.D., Ad Hoc Member
Marcelle I. Cedars, M.D., Ad Hoc Member
Robert E. Brannigan, M.D., Ad Hoc Member
Robert W. Rebar, M.D., ASRM Executive Director
Andrew R. La Barbera, Ph.D., H.C.L.D., ASRM Scientific Director
Lee Hutchison Boughton, M.A., ASRM Scientific Program Coordinator
Penelope Fenton, M.A., ASRM Postgraduate Program Coordinator
ASRM VIDEO COMMITTEE
Steven F. Palter, M.D., Chair
Tien-cheng A. Chang, Ph.D.
Tommaso Falcone, M.D.
Emilio Fernandez, M.D.
Antonio R. Gargiulo, M.D.
Arik Kahane, M.D.
Philip S. Li, M.D.
Stephen R. Lindheim, M.D.
Marius Meintjes, D.V.M., Ph.D.
Dana A. Ohl, M.D.
David L. Olive, M.D.
Marc P. Portmann, M.T.
Togas Tulandi, M.D.
Paul J. Turek, M.D.

IFFS OFFICERS AND BOARD OF DIRECTORS 2010 - 2013
IFFS OFFICERS
Joe Leigh Simpson (USA), President
Richard Kennedy (UK), Secretary General
Gabriel de Candolle (Switzerland), Assistant Secretary General
Edgar Mocanu (Ireland), Treasurer
Mauricio Abrao (Brazil), Assistant Treasurer
Basil Tarlatzis (Greece), Past President
Paul Devroey (Belgium), Director of Medical Education
David Healy (Australia), President 2010-2012
IFFS BOARD OF DIRECTORS AND THEIR MEMBER SOCIETIES
American Society for Reproductive Medicine G. David Adamson 2007-2016
Argentine Society for Reproductive Medicine Marcos Horton 2010-2019
Colombian Association of Fertility and
Reproductive Medicine Jose Ignacio Madero 2004-2013
Fertility Society of Australia Ossie Petrucco 2004-2013
German Society of Reproductive Medicine Tina Buchholz 2004-2013
Indian Society of Assisted Reproduction Dhiraj Gada 2010-2019
Japan Society of Reproductive Medicine Minoru Irahara 2007-2016
Jordanian Society for Fertility and Genetics Mazen El-Zibdeh 2010-2019
Swedish Society of Obstetrics and Gynecology Pietro Gambadauro 2007-2016
ASRM OFFICERS AND BOARD OF DIRECTORS 2012 - 2013
ASRM OFFICERS
Linda C. Giudice, M.D., Ph.D., President
Richard H. Reindollar, M.D., President-Elect
Rebecca Z. Sokol, M.D., M.P.H., Vice President
Dolores J. Lamb, Ph.D., H.C.L.D., Immediate Past President
Roger A. Lobo, M.D., Past President
Catherine Racowsky, Ph.D., H.C.L.D., Secretary
Stuart S. Howards, M.D., Treasurer
ASRM BOARD OF DIRECTORS AND THEIR MEMBER SOCIETIES
Marc Fritz, M.D.
Nancy Brackett, Ph.D.
Marcelle I. Cedars, M.D.
Christos Coutifaris, M.D., Ph.D.
Richard S. Legro, M.D.
Hugh S. Taylor, M.D.
Steven T. Nakajima, M.D. (SREI)
Grace Janik, M.D. (SRS)
Grace Centola, Ph.D., H.C.L.D. (SMRU)
Thomas Turner, Jr., E.L.D., M.S. (SRBT)
David Ball, Ph.D., H.C.L.D. (SART)
ASRM EXECUTIVE DIRECTOR
Robert W. Rebar, M.D.
ASRM SCIENTIFIC DIRECTOR
Andrew R. La Barbera, Ph. D., H.C.L.D.
Ex Officio

IFFS/ASRM Annual Meeting
Policies and Disclaimers
CANCELLATION POLICY
The International Federation of Fertility Societies and the American Society for Reproductive
Medicine reserve the right to cancel this activity due to unforeseen circumstances. In the event of
such cancellation, the full enrollment fee will be returned to the registrant.
REFUND/NON-ATTENDANCE POLICY
Cancellations received before or by September 12th will receive a full refund minus a $50 processing
fee. Cancellations received after September 12th will not be eligible for a refund.
ADA STATEMENT
Medicine fully comply with the legal requirements of the ADA and the rules and regulations thereof.
Accommodations for Disabilities: Please notify the American Society for Reproductive Medicine, 1209
Montgomery Highway, Birmingham, Alabama, USA 35216, telephone 1-205-978-5000, a minimum of
10 working days in advance of the event if a reasonable accommodation for a disability is needed.
EQUAL OPPORTUNITY STATEMENT
Medicine value and promote diversity among its members, officers and staff. The Societies prohibit
discrimination toward any member or employee due to race, color, religion, age, gender, sexual
orientation, national origin, citizenship, disability, military status or other basis prohibited by law.
IFFS and ASRM strive to achieve gender, racial and ethnic balance in hiring and governance. IFFS
and ASRM maintain policies, procedures and personnel actions that conform to the letter and spirit
of all laws and regulations pertaining to equal opportunity and nondiscrimination in employment,
appointments and elections to office.
DISCLAIMER STATEMENT
The content and views presented in this educational activity are those of the faculty/authors and do
not necessarily reflect those of the International Federation of Fertility Societies and the American
Society for Reproductive Medicine. This material is prepared based upon a review of multiple sources
of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and
other individuals should review and consider other publications and materials on the subject matter
before relying solely upon the information contained within this educational activity to make clinical
decisions about individual patients.
Room numbers of sessions are listed in the meeting app,
the fold-out Schedule-at-a-Glance
and on signage throughout the convention center.
14

Continuing Education Credit
Continuing education/continuing medical education credit is not
offered during meals, breaks, receptions/cocktail parties, training
sessions, satellite meetings or any private group meeting (e.g.,
council meetings, invitation-only meetings, editorial board meetings,
etc.). In addition, CME credit is not offered during poster sessions,
oral abstract presentations, or roundtable luncheon discussions.
All activities are for CME, unless
otherwise noted.
Indicates a postgraduate course that
qualifies for CE credit.
Indicates Audience Response System
(ARS) will be used during session.
Non- CE ARS
CME
Continuing medical education is a lifelong learning modality enabling physicians to remain current with medical advances. The goal of
ASRM is to sponsor educational activities that provide learners with the tools needed to practice the best medicine and provide the best,
most current care to patients.
As an accredited CME provider, ASRM adheres to the Essentials and Policies of the Accreditation Council for Continuing Medical
Education (ACCME). CME activities now must first, address specific, documented, clinically important gaps in physician knowledge,
competence or performance; second, be documented to be effective at increasing physician knowledge, skill or performance; and
third, conform to the ACCME Standards for Commercial Support.
ASRM must not only obtain complete disclosure of commercial and financial relationships pertaining to reproductive medicine but also
resolve any perceived conflicts of interest. All postgraduate course faculty members and all organizers, moderators and speakers in the
Scientific Program have completed disclosures of commercial and financial relationships with manufacturers of pharmaceuticals,
laboratory supplies and medical devices and with commercial providers of medically-related services. The disclosures were reviewed by
the Subcommittee for Standards of Commercial Support of the ASRM CME Committee, which resolved perceived potential conflicts of
interest.
The next few years will be an exciting time for the community of reproductive medicine practitioners as we adapt to the changing
environment of healthcare and CME. The American Medical Association is advancing a transition of CME from a system of credits based
on hours of attendance to a system based on improvement in physician performance.
15
Continuing Education Credit Information will be located in the front
of each Postgraduate Course syllabus and the Final Program.
CE/CME Credit reporting is done online. You will receive an
email requesting you to log-in to complete evaluations of the
Postgraduate and Scientific Programs and claim your AMA,
ACOG, NASW and Nursing credits, or to request a Certificate of
Attendance. The Website contains detailed instructions on how
to complete the report and you will be able to print or email a
certificate to the email address you provided at registration. Final
date to report credit is December 31, 2013.
Credits other than those specified below are the responsibility of
each attendee.
Commercially Supported Symposia
Commercially Supported Symposia presented at the Annual
Meeting of the ASRM are a part of the Scientific Program, unless
otherwise noted.
The Accreditation Council for Continuing Medical Education
(ACCME)
The American Society for Reproductive Medicine is
accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
Scientific Program Designation Statement
The American Society for Reproductive Medicine designates this
live activity for a maximum of 25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
Postgraduate Program Designation Statement
The American Society for Reproductive Medicine designates this
live activity for a maximum of 6.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the
extent of their participation in the activity. Postgraduate Course 27
is approved for a maximum of 13 AMA PRA Category 1 Credits™.
The American College of Obstetricians and Gynecologists
Tthe American College of Obstetricians and Gynecologists has
assigned 25 cognates to the Scientific Program and 7 cognate to
the one-day Postgraduate Program.
American Board of Bioanalysis (ABB)
The American Society for Reproductive Medicine has applied to
provide Professional Enrichment Education Renewal (PEER) credit
through the American Board of Bioanalysis. PEER CEUs will be
recognized for the Scientific Program. CEUs will be recognized for
postgraduate courses 1, 4, 11, 12, 17, 21, 22, 24 and 27. PEER credit
forms for eligible postgraduate courses and for the Scientific
Program will be available at the American Association of
Bioanalysts (AAB) booth in the Exhibit Hall. ABB certification exams
will be administered Friday, October 11, 2013.
American Psychological Association (APA)
The Mental Health Professional Group (MHPG) of the
American Society for Reproductive Medicine is approved
by the American Psychological Association to sponsor
continuing education for psychologists. The MHPG maintains
responsibility for this program and its content. Application for credits
has been made.
National Association of Social Workers (NASW)
Mental Health Professional Group postgraduate course 10 has been
approved by the National Association of Social Workers (approval
#886496548-2006) for 6.5 Social Work continuing education hours.
Nursing Credits
The Continuing Education Approval Program of the National
Association of Nurse Practitioners in Women’s Health has approved
the Scientific Program for 23.25 contact hours of continuing
education credit, including 15 of pharmacology. Postgraduate
Course 03 has been approved for 6.50 contact hours of continuing
education credit, including 2.0 hours of pharmacology.
Genetic Counselor CEUs
Postgraduate Course 09 has been submitted to the National Society
of Genetic Counselors (NSGC) for approval of Category 1 CEUs.
The American Board of Genetic Counseling (ABGC) accepts CEUs
approved by NSGC for purposes of recertification. Approval for the
requested CEUs and Contact Hours is currently pending.
Note: No credits will be given for Association of Reproductive Managers
Continuing Education Course PG8.
CERTIFICATE OF ATTENDANCE
Proof of attendance is available on request from J Spargo at the registration desk. Continuing Education Credit information is located in the front of the
Postgraduate Course syllabi, and the Final Program and online.
ADMISSION BADGES
Name badges will be issued for the Postgraduate and Scientific Programs and are required for admission. Spouse/guest badges will be issued and are required
for admission to spouse/guest activities and the Exhibit Hall.
PHOTO/AUDIO/VIDEO RECORDING
Photographing or audio/video recording of any session for personal or commercial purposes without permission is prohibited.

Disclosure Statements/Conflict of Interest Policy
2013 IFFS/ASRM Conflict of Interest
Honoraria Policy for Invited Speakers
The following speakers may receive
honoraria and/or discounted or free
registration:
16
• Plenary Speakers
• Postgraduate Course Faculty
• Trilogy Speakers
• Symposia Speakers
• Interactive Session Speakers
The following speakers do not
receive honoraria:
• Roundtable Presenters
• Abstract Presenters
• Video Presenters
Disclosure Statements
Postgraduate Faculty, Symposium
Speakers, Plenary Lecturers, Abstract
Authors, Trilogy Speakers, Abstract
Graders, Roundtable Presenters, Video
Presenters, and Interactive Speakers
are required to disclose commercial
relationships or other activities that
might be perceived as potential
conflicts of interest.
Postgraduate course faculty
disclosures will be listed in the course
syllabi.
Symposium speakers’ disclosures will
be presented in handout materials,
as well as on slides.
Disclosures from speakers in the
Plenary Sessions, Interactive Sessions,
Roundtables, Videos and Symposia
will be published in the Final Program.
Abstract authors’ disclosures will be
published in the 2013 Program
Supplement.
Each presenter should reveal his/her
disclosure information during his/her
presentation, preferably with the
visual aid of a slide.
Roundtable presenters should
provide a copy of their disclosure
forms to the participants at their
table.
As a provider of continuing medical education (CME) accredited by the
Accreditation Council for Continuing Medical Education (ACCME), the
American Society for Reproductive Medicine must ensure balance,
independence, objectivity and scientific rigor in all its educational activities.
All presenters must disclose to the learners any commercial or financial
interests and/or other relationships with manufacturers of pharmaceuticals,
laboratory supplies and/or medical devices. All relationships, whether or
not they directly apply to this CME event, must be disclosed. All non-FDA
approved uses of products must be clearly identified. Disclosures may be
made in the form of a slide, printed material, or oral statement.
The intent of this disclosure is not to prevent a speaker with a commercial or
financial interest from making a presentation. The intent is to assist ASRM
in resolving conflicts of interest and to provide learners with information on
which they can make their own judgments regarding any bias. Although
ASRM reviews and resolves potential conflicts of interest, it remains for the
audience to determine whether the speaker’s interests or relationships may
influence the presentation with regard to exposition or conclusion.
Disclosures will be revealed to the learners. For postgraduate courses,
disclosure information will be provided in the syllabus. For other activities,
where no syllabus or other similar printed material is available, disclosures
must be made verbally to the audience by the speakers, preferably with the
visual aid of a slide.
For those situations where there is no potential for conflict of interest, the
portion of the form that so states should be completed. In those situations
where a speaker does not complete a form or refuses to complete a form, the
individual is ineligible to participate as a speaker in the CME activity.
Speakers should also reveal to the audience any “off label” uses
(not approved by the FDA) of any drugs or products discussed.
Abstract authors’ disclosures are listed in the 2013 Program Supplement.
Speakers in the Symposia and Interactive, Video, Roundtable and Abstract
Sessions have also complied with ASRM policies and their disclosures are printed
in the ASRM Final Program. The speaker should reveal this information during
his/her presentation, preferably with the visual aid of a slide.
Continuing Medical Education and
Continuing Education Credits will be available.

Postgraduate Program
17
46TH ANNUAL
POSTGRADUATE
PROGRAM
COMMITTEE
CHAIR
Anuja Dokras, M.D., Ph.D.
CO-CHAIR
Lisa M. Halvorson, M.D., Ph.D.
COORDINATING CHAIR
Kathleen Hwang, M.D.
AD HOC
Bradley J. Van Voorhis, M.D.
WEEKEND COURSES
Dates:
Saturday, October 12TH
Sunday, October 13TH
Hours:
8:15 a.m.-5:00 p.m.
Lunch is from Noon-1:00 p.m.
Courses PG1-PG13 are one-day
courses on Saturday.
Courses PG14-PG26 are one-day
courses on Sunday.
Course PG27 is a two-day course
on Saturday and Sunday.
Postgraduate Course
Syllabi will be posted
online in
September 2013.
Printed copies will be
distributed on-site.
One-Day Courses
Saturday, October 12, 2013
GLOBAL APPROACHES TO PREVENTING INFECTIONS IN THE ART
LABORATORY: FROM THEORY TO PRACTICE
Course PG1 (Saturday)
Developed in Cooperation with the International Federation of Fertility Societies
FACULTY
Deborah J. Anderson, Ph.D., Chair
Boston University School of Medicine
Carole M. Gillings-Smith, Ph.D.
Agora Gynecology and Fertility Center
Augusto Enrico Semprini, M.D.
University of Milan Medical School
NEEDS ASSESSMENT AND COURSE DESCRIPTION
Different regions of the world have different infections in the population that impact the
practice of assisted reproductive technologies. The challenge for laboratory and clinical
staff of ART clinics is to prevent transmission of infectious agents to the mother or
gestational carrier and to the offspring of ART procedures. The objective of this live course
is to train all members of the professional ART team to implement clinical and laboratory
procedures to reduce the risk of transmission of infectious agents.
ACGME Competency
Patient care
LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:
1. Summarize the prevalence and characteristics of concern in different populations
around the world.
2. Design and implement practices to prevent infection in ART clinics in developed
countries.
3. Discuss implementation of procedures to prevent infection in ART clinics in
developing countries.
CODING FOR REPRODUCTIVE MEDICINE PRACTICES 2013
ARS
Developed in Cooperation with the American Society for Reproductive Medicine Coding Committee
FACULTY
John T. Queenan Jr., M.D., Chair
University of Rochester Medical Center
George A. Hill, M.D.
Nashville Fertility Center
Every reproductive medicine practice has a legal and ethical obligation to follow a specific
set of rules and regulations that determine how reimbursements are calculated. Failure
to follow these rules can result in unfair practices to patients and/or legal consequences
from government or third-party payers. The problem is those rules and regulations have
become so complex that most people cannot understand them without receiving special
training.
This live course, designed for physicians, practice managers, billers, office managers,
sonographers, laboratory managers, and physician assistants, will include didactic
lectures, panel discussions, case presentations and interactive question and answer
sessions. The correct way to report diagnostic codes and select the appropriate procedure
codes will be explained, with a focus on quality improvement and minimizing errors.
Systems-based resources available to aid in improving patient billing accuracy will be
addressed, as will information technology resources that provide participants with the

46TH ANNUAL POSTGRADUATE PROGRAM
ability to continue updating their knowledge of correct coding in the future. Special attention will be given to the upcoming changes in
the International Statistical Classification of Diseases and Related Health Problems (ICD), 10th Revision.
ACGME Competency
Systems-based practice
LEARNING OBJECTIVES
1. Demonstrate correct coding of diagnostic conditions that are typically encountered in the practice of reproductive endocrinology.
2. Identify the correct Current Procedural Terminology (CPT) code for surgical procedures encountered in the practice of reproductive
endocrinology and list additional resources available to aid with correct coding procedures in the future.
3. Summarize the rules and regulations required by third-party payers regarding documentation guidelines to verify that physician
services were rendered according to medical necessity and in accordance with the requirements of CPT.
4. Describe the proper steps for successful verification or negotiation of coverage in obtaining third-party payer coverage for fertility
COMPLICATIONS OF ART: IN SEARCH OF A HAPPY ENDING
Developed in Cooperation with the Nurses’ Professional Group
FACULTY
Angela Smith, N.P., Chair
Anderson-Smith Associates
Tamara M. Tobias, A.R.N.P., Co-Chair
Seattle Reproductive Medicine
Joanne Stone, M.D.
Mt. Sinai School of Medicine
Lauri A. Pasch, Ph.D.
University of California, San Francisco
The successful outcome of fertility treatment brings joy to many couples. Unfortunately, some treatments result in complications that
present complex issues and require special management strategies. These may include ovarian hyperstimulation syndrome (OHSS),
ectopic pregnancy, pregnancy loss, multiple pregnancy and treatment failure. Psychological complications such as depression, isolation
and relationship strain may add additional obstacles. Health care providers must understand the problems that may occur, discuss
treatment and management strategies, and recognize when referrals or other resources are needed. The factors that may prevent
or reduce the risk of ovarian hyperstimulation syndrome and management strategies for ectopic and multifetal pregnancy will be
addressed in this course. The psychological complications of pregnancy loss and treatment failure will be examined. In addition, the
psychosocial issues of depression, isolation and relationship stressors will be explored. The goal of this live course is to increase the
ability of nursing professionals to avoid potential complications of fertility treatment and to provide patients with strategies to navigate
their fertility journeys.
ACGME Competency
Practice-based learning and improvement
LEARNING OBJECTIVES
1. Discuss OHSS and various strategies to prevent this syndrome and the effectiveness of those strategies.
2. Review the management and impact of an ectopic pregnancy.
3. Explore the emotional influence of treatment failure and pregnancy loss.
4. Explain the unique issues confronting multifetal pregnancies and current treatment strategies.
5. Examine the psychological implications of depression, isolation and relationship stressors that may ensue from fertility treatment.
18
services.
Non-
CME
CE ARS

CRYOPRESERVATION OF REPRODUCTIVE CELLS AND TISSUES:
REAL WORLD APPROACHES AND LABORATORY PEARLS
Developed in Cooperation with the Society of Reproductive Biologists and Technologists
ARS
FACULTY
Amy E. T. Sparks, Ph.D., Chair
Reproductive Biology Resources, Inc.
Alison Finn, M.S.
University of Connecticut Health Center
Kyle E. Orwig, Ph.D.
University of Pittsburgh
Linda J. Siano, M.A., M.S., E.L.D.
University of Connecticut Health Center
Cryopreservation of reproductive cells and tissues has been practiced for more than half a century. However, lack of consensus on
best practices has led to variable cryopreservation success rates that may hamper clinical utilization. While human sperm has been
cryopreserved for decades, techniques such as oocyte vitrification are relatively recent technology breakthroughs. The learning
curve for some of these techniques can be steep and best practices for how to determine a laboratory’s competence to perform the
procedures are still evolving. As the types of patients who are candidates for cryopreservation procedures expand beyond fertility
patients to include those with chronic diseases, it may not be feasible to mount multiple attempts at cryopreservation. Optimizing
outcomes from the outset will be critical. Review of the Society for Assisted Reproductive Technology (SART) outcome statistics
indicate the outcomes with cryopreservation of embryos vary by center, and strategies for assessing the cause of the variability must be
developed before the technique is offered to patients who may have only one chance for a successful outcome (e.g., cancer patients).
At the same time, long-term storage of these frozen cells and tissues presents challenges to long-term success. Cells formerly stored
for several years may now be stored for decades. As frozen egg banks become more common, the lessons learned from years of
sperm banking should not be lost and good tissue-banking practices must be implemented. Finally, experimental techniques that
broaden the types of tissues that can be cryopreserved are in use at some centers. Knowledge of these methods, including their
strengths, weaknesses and limitations, is essential in determining if they are safe and efficacious and ready to move into widespread
use or should be reserved for specialized centers. This live course for laboratory clinicians will cover current cryopreservation
techniques and their application outside of infertility treatment, instituting competency-based training in laboratories, and issues of long-term
19
storage of cells and tissues.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Describe the scope of the clinical use of cryopreservation of reproductive tissues and cells outside of infertility treatment.
2. Assess the best methods for cryopreservation according to tissue type, including factors that can limit success.
3. Design a plan for competency-based training that can be instituted for each cell or tissue type.
4. Discuss the unique technical, financial, logistical and regulatory challenges of long-term storage of reproductive cells and tissues.
5. Compare and contrast the practice of long-term banking of anonymous sperm donors with that of egg donors and answer the
question: “What can egg banks learn from sperm banks?”
A SIMPLIFIED RISK-FREE IVF WITHOUT COMPROMISING OUTCOME
Developed in Cooperation with the Middle East Fertility Society
FACULTY
Mohamed Aboulghar, M.D., Chair
Cairo University and the Egyptian IVF Center
Mina Alikani, Ph.D., H.C.L.D.
Tyho-Galileo Research Laboratories
Paul Devroey, M.D., Ph.D.
University Hospital Brussels
David R. Meldrum, M.D.
Reproductive Partners Medical Group, Inc.
The success of in vitro fertilization (IVF) is affected by patients’ reproductive status, the stimulation protocol and the quality of gametes
and embryos. These parameters can vary greatly among IVF clinics. It is necessary to optimize the clinical and laboratory procedures
to ensure the highest quality embryos. This live course for physicians, nurses and laboratory staff of IVF clinics is designed to highlight
the latest medical evidence in assisted reproductive technology. The course will describe how to simplify the IVF procedure beginning

with stimulation protocols. The faculty will address minimal monitoring, newer options for triggering ovulation, assuring safety of IVF
by prevention of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy, and simplifying the laboratory and freezing
procedures without reducing the pregnancy rate.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Perform natural- and clomiphene-cycle IVF.
2. Describe the soft protocols for ovarian stimulation in IVF.
3. Explore newer options for triggering ovulation with minimum risk.
4. Avoid OHSS in performing IVF.
5. Discuss the benefits and risks of single-embryo transfer and cryopreservation.
CROSSING BORDERS AND OTHER HOT LEGAL ISSUES
FOR THE HEALTHCARE PROVIDER AND LEGAL PRACTITIONER
Developed in Cooperation with the Legal Professionals Group
FACULTY
Nidhi Desai, J.D., Chair
Ballard, Desai & Miller
Judith F. Daar, J.D.
Whittier Law School
Andrew W. Vorzimer, J.D.
Vorzimer Masserman
Colleen M. Wagner-Coughlin, M.S.
aParent IVF
The involvement of third parties in assisted reproduction as gamete and embryo donors and as gestational carriers has produced a
plethora of legal issues for the reproductive healthcare professional. Confronted with the complicated relationships among intended
parents, gamete donors and gestational surrogates, the medical team often does not appreciate the legal implications of treating
patients from different countries. While medical practitioners should not offer legal advice, awareness of the legal complexities and
possible landmines their patients may encounter with respect to immigration, contract enforceability and parentage will help better serve
practices and patients. Recognition of those arrangements that require a partnership of legal and medical experts is essential in the
creation of legally-secure families. The medical practitioner often has a lack of understanding of legal issues related to developments in
new technologies and the interaction of the laws of various jurisdictions when treating or advising international clients.
This live course will provide guidance to the healthcare practitioner and lawyer advising patients who are traveling from other
countries as well as those patients traveling out of the United States for treatment. Topics will include treatment, parentage, immigration,
and contract enforceability given the intersection of multiple jurisdictions. The course will further explore current hot topics in assisted
reproductive technology such as egg freezing and international regulations. This presentation is designed to review commonly-encountered
situations that are subject to legal scrutiny, define the legal issues and potential pitfalls, provide practical solutions to
roadblocks in assisted reproductive technology arrangements and explore the legal significance of treating clients from other countries.
The various speakers will further address issues emerging as a result of newer technology based on legal precedent and principles.
Each presenter will field questions from attendees that will allow for discussion of particular clinical conundrums, with the opportunity to
develop usable solutions for clinical practice. This program will feature a practical approach to help lawyers and physicians better field
situations as they arise.
ACGME Competency
LEARNING OBJECTIVES
1. Explain problematic issues arising out of cross-border care.
2. Construct specific steps for clinics to take to protect their programs and patients.
3. Discuss some of the emerging legal challenges brought on by newer assisted reproductive technologies.
4. Formulate practical methods of dealing with these emerging issues.
20

ULTRASOUND IMAGING IN ART
Developed in Collaboration with the American Institute of Ultrasound in Medicine
FACULTY
Laurel A. Stadtmauer, M.D., Ph.D., Chair
Eastern Virginia Medical School
Todd Deutch, M.D., Co-Chair
Advanced Reproductive Center
Botros Rizk, M.D.
University of South Alabama
James M. Shwayder, M.D., J.D.
University of Mississippi Medical Center
Ultrasound has become the most widely used and important tool in diagnosis and treatment of infertility. Ultrasound and ultrasound-guided
procedures have become integral components not just of assisted reproductive technology (ART), but also in the day-to-day
practice of reproductive medicine, infertility and gynecology. 3-D ultrasound allows better imaging, as well as more accurate volume
rendering. It has become the gold standard for the diagnosis of uterine anomalies, and may assist in more accurate follicular monitoring
measurements. In 2009, new practice guidelines for ultrasound in reproductive medicine were published by the American Institute of
Ultrasound in Medicine (AIUM) and in collaboration with the American Society for Reproductive Medicine (ASRM). Surveys of members
of the Society for Reproductive Endocrinology and Infertility, the Imaging Special Interest Group and ASRM have revealed a strong
desire for CME credits in ultrasonography that would prepare reproductive medicine professionals and gynecologists for accreditation
by AIUM. In addition, there is an interest in training and credentialing reproductive nurses and nurse practitioners to perform limited
ultrasounds in the office.
This live one-day course, designed to meet the needs of physicians and other healthcare providers who use gynecologic sonography,
will fulfill CME requirements for AIUM credentialing. The objective of this course is to provide a comprehensive survey of the use of
ultrasonography in the female pelvis for physicians, nurses and ultrasonographers actively involved in reproductive medicine, infertility
and gynecology.
This course will emphasize the use of ultrasound in maximizing ART success and including follicular monitoring with 3-D sonographic
automatic volume calculation, assessment of the uterine lining during retrieval and embryo transfer in an evidence-based manner.
Newer technologies, such as 3-D ultrasound, Doppler and the use of CT- and MRI-guided procedures, will also be discussed, along
with cost-effective current or potential applications. Participants will be encouraged to actively take part in case presentations and
discussions of controversies. Practical applications of the technology will be addressed along with case presentations, and participants
will have the opportunity to manipulate 3-D images.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Summarize the appropriate use of ultrasonography in the evaluation of infertility, uterine abnormalities and the pathology of the
21
reproductive tract.
2. Describe the proper assessment of early pregnancy and list findings on early pregnancy assessments that are associated with
poor outcome.
3. Discuss the importance of 3-D ultrasonography in reproductive medicine, and the importance of Doppler blood-flow assessment in
reproductive medicine and gynecology.
4. Evaluate the use of fallopian tube patency with ultrasound.
5. Critically evaluate how ultrasound can maximize the success of ART.

CRITERIA FOR WORLD-CLASS PERFORMANCE EXCELLENCE
Non-
CME
Developed in Cooperation with the Association of Reproductive Managers
FACULTY
Joseph J. Travia, M.B.A., Chair
Center for Reproductive Medicine
Paul A. Bergh, M.D.
Reproductive Medicine Associates of New Jersey
Barbara Schmidt-Kemp, B.A.
North Star Consultants, LLC
Reproductive medicine facilities are confronted with more challenges than ever before from patients expecting world-class service and
results. With slower annual growth and a competing global economy, being good is no longer an option; patients want the best. Patients
are well informed through social media and other Internet resources, and their expectations for good outcomes continue to rise. Their
initial selection of a clinic will be based on cutting-edge technology and published results. If patients remain with their initial selection,
that decision will be based on the level of service they received during their first visit. Scientific breakthroughs continue to provide new
opportunities for meeting the needs of assisted reproductive technology (ART) patients world-wide.
This live course is designed for practitioners wanting to create a world-class experience for their patients through performance
excellence at every level of their organization. From creative leadership, strategic planning, patient focus, measurement, analysis
and knowledge management to work environment and employee engagement, this course will enable every participant to contribute
significantly to their practice's reach for excellence.
ACGME Competency
LEARNING OBJECTIVES
1. Formulate the critical logistics of strategic planning and implementation, with a focus on patient recruitment and retention.
2. Convert strategic objectives into action plans, along with key action plan indicators to measure competency and performance
THE ART OF GENETICS: REPRODUCTIVE GENETICS IN THE ART SETTING
22
results in the practice.
3. Provide a world-class work environment that promotes creative leadership and employee engagement.
4. Determine the best, most competitive healthcare service offerings for the practice, and the most effective patient and stakeholder
communication vehicles to market those opportunities.
5. Measure, analyze, review and improve performance at all levels of the organization through the information already available in
clinical, laboratory, and operations databases.
CE
Developed in Cooperation with the Genetic Counseling Special Interest Group
FACULTY
Jill M. Fischer, M.S., C.G.C., Chair
Reprogenetics
Lauri D. Black, M.S., L.C.G.C.
Pacific Reproductive Genetic Counseling
Gabriel A. Lazarin, M.S., C.G.C.
Counsyl
Amy C. Vance, M.S., C.G.C.
Bay Area Genetic Counseling
Reproductive genetics is an increasing part of the assisted reproductive technology (ART) practice. Daily, ART centers use genetic
information when couples undergo ethnicity screening, when donors are screened and chosen for recipient couples, to determine the
cause of infertility or recurrent pregnancy loss, and when utilizing preimplantation genetic screening (PGS) and preimplantation genetic
diagnosis (PGD). However, the application of genetic information and genetic testing is often limited due to lack of knowledge by the
medical providers in the ART practice. Education of these medical providers is incomplete and most ART centers do not have a genetic
counselor on staff.
This live course serves to provide basic to complex genetic information to help such practices start to fill this education gap and
competently apply genetic information to improve patient care. The course will provide both basic genetics education and review of
real time application. The faculty will address current knowledge of the genetic causes of male infertility not limited to cystic fibrosis
and genetic causes of female infertility, including the latest research on and testing for fragile X syndrome. As high throughput carrier
testing options become more readily available, current American Society for Reproductive Medicine (ASRM), American College of
Obstetricians and Gynecologists (ACOG) and American College of Medical Genetics (ACMG) carrier testing guidelines will be outlined

and the application of such testing discussed. Current PGS/PGD test techniques and applications will be examined. Overall, this course
should educate the ART medical professionals on current genetic information and test options so they can improve patient care in their
practices.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Explain genetic inheritance patterns, risk assessment and ethnicity screening.
2. Describe genetic and chromosomal causes of male and female infertility and infertility test options.
3. Define genetic and chromosomal test options for recurrent pregnancy-loss patients.
4. Outline donor carrier screening guidelines by ASRM, ACOG and ACMG and their application to current practice.
5. Evaluate the value of high throughput carrier screening in the ART setting and review current test techniques and applications of
23
PGD.
NEW FAMILIES ON TRIAL
Developed in Cooperation with the Mental Health Professional Group
FACULTY
Andrea Mechanick Braverman, Ph.D., Chair
Jefferson Medical College
Nanette Elster, J.D., M.P.H.
Health Law Institute
Julia Woodward, Ph.D.
Duke University Medical Center
The idea of Mommy and Daddy and baby makes three as depicted in the 1950s “Leave it to Beaver” representation of the family has
been put into rerun by the new American family of “Modern Family” and “Two and a Half Men.” Many of the new families are made
possible only by assisted reproductive technology (ART). Single mothers by choice and single fathers by choice are emerging as
“choice” families. Co-in vitro fertilization (IVF) with lesbian partners sharing the genetic and gestational contribution to their children is
now a common procedure. On the horizon are families where Mom freezes her eggs in her 20s or 30s but is now ready to fertilize an
egg and get pregnant in her 40s and 50s.
This live course will increase mental health professionals’ understanding of the many new ART families. This course will provide
participants with the current research and theories explaining the needs and challenges for these families. Utilizing an interactive format
of a mock trial, participants will have the opportunity to hear “testimony” and be “the jury” to identify the issues and concerns of these
ART families. This course will equip mental health professionals in providing competent understanding and sensitivity to the ever-expanding
All-American family.
ACGME Competency
Interpersonal and communication skills
LEARNING OBJECTIVES
1. Describe the different types of families made possible by ART.
2. Discuss the current literature on the new ART families.
3. Explain the challenges to providers in counseling these new ART families.
Non-
CME
CE ARS

THIRD PARTY REPRODUCTION IN THE UNITED STATES:
LEGAL, MEDICAL AND PSYCHOLOGICAL/ETHICAL ASPECTS
Developed in Cooperation with the Society for Assisted Reproductive Technology
FACULTY
James M. Goldfarb, M.D., Chair
University Hospitals of Cleveland
Susan L. Crockin, J.D.
Georgetown University Law Center/Crockin Law & Policy Group, LLC
Julianne E. Zweifel, Ph.D.
University of Wisconsin
Third-party reproduction, particularly oocyte donation (OD) and gestational surrogacy (GS), has received much professional and public
attention recently. Both of these procedures have been utilized since the mid-1980s, but as they have evolved, the medical, legal and
psychological/ethical complexities have all increased. It is imperative that individuals involved with these procedures be aware of all the
complex issues involved. Embryo donation (ED) and sperm donor insemination (DI) have attracted less attention and are medically not
as complex as OD and GS. However, they, too, are associated with significant legal and psychological/ethical issues.
This live course, designed for medical professionals involved in assisted reproductive technology (ART), examines the medical, legal
and psychological/ethical issues involved in OD and GS, and to a lesser extent, ED and DI. Medical topics to be discussed include:
safety considerations and inclusion/exclusion criteria for egg and sperm donors and gestational surrogates, number of embryos to
transfer in egg and embryo donor and gestational surrogate cycles, and role of oocyte cryopreservation in OD cycles. Legal topics will
include: model legislation by the American Bar Association, variation in regulation of third-party reproduction in different states, new
legislative proposals to regulate third-party reproduction, informed consent and legal pitfalls. Psychological/ethical issues will include:
egg donor and gestational surrogate payment, participant coercion, shared egg donation, divulging to offspring, and psychological
aspects and screening tools of third-party reproduction.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Explain the legal issues regarding OD, GS, ED and DI, particularly regarding state legislative efforts to regulate third-party
24
reproduction.
2. Discuss issues with egg donation, including establishment of a national egg donor registry, differences between anonymous and
directed egg donation, and guidelines for payment of egg donors.
3. Discuss the medical procedures involved with third party reproduction.
ENDOMETRIUM AND EMBRYO CROSS-TALK: HOW TO PREDICT AND ACHIEVE IMPLANTATION SUCCESS
ARS
Developed in Cooperation with the European Society of Human Reproduction and Embryology
FACULTY
Antonis Makrigiannakis, M.D., Ph.D., Chair
University of Crete Medical School
Roy G. Farquharson, M.D.
Liverpool Womens Hospital
Sophia N. Kalantaridou, M.D., Ph.D.
University of Ioannina Medical School
Ioannis E. Messinis, M.D., Ph.D.
University of Thessalia
During implantation, the cross-talk between the embryo and the endometrium remains largely unknown. Local and systemic players
interact for the achievement of human pregnancy. Impaired implantation is currently considered the most important limiting factor for the
establishment of viable pregnancies in assisted reproduction. It is expected that elucidating the molecular background of the process
will enable accurate diagnosis and effective treatment of implantation failure and/or miscarriages. The purpose of this live course for
embryologists and clinical reproductive medicine specialists is to identify factors that predict implantation success and investigate
potential treatment modalities to manage implantation failure and/or miscarriages.
ACGME Competency
Medical knowledge

LEARNING OBJECTIVES
1. Summarize the physiology and pathophysiology of implantation.
2. Describe local and systemic factors leading to miscarriages and/or implantation failure.
3. Discuss the challenges of predicting and achieving implantation success.
MODERN MANAGEMENT OF POLYCYSTIC OVARY SYNDROME IN ADOLESCENTS
Developed in Cooperation with the Pediatric and Adolescent Gynecology Special Interest Group
FACULTY
Jennifer E. Dietrich, M.S., M.Sc., Chair
Baylor College of Medicine
Beth W. Rackow, M.D.
Columbia University
Samantha M. Pfeifer, M.D.
University of Pennsylvania Medical School
Staci Pollack, M.D.
Albert Einstein College of Medicine
Polycystic ovary syndrome (PCOS) affects an estimated 5-7% of women of reproductive age. True estimates are difficult to define in
adolescents, but have been postulated to be higher. Because PCOS is associated with comorbidities such as diabetes mellitus type II,
hypertension, non-alcoholic steatosis and obesity as well as other health problems, it is critical to establish an early diagnosis to avoid
significant health problems later in life.
This live course designed for clinicians who care for adolescent females will cover current scientific papers and new areas of research
that focus on adolescent needs and screening. Through a lecture/audience participation format, participants will discuss early warning
signs such as precocious adrenarche that help providers determine the best time to screen adolescents for PCOS, which should result
in improved patient lifelong health.
ACGME Competency
Medical knowledge
LEARNING OBJECTIVES
1. Confidently perform an evaluation for PCOS on an adolescent female.
2. Differentiate adult criteria from adolescent criteria in making the diagnosis of PCOS.
3. Detect early warning signs indicating a possible diagnosis of PCOS in the adolescent and evaluate the need for early screening
25
and early intervention.
4. Discuss the available treatment options for adolescents with PCOS.

One-Day Courses
Sunday, October 13, 2013
PCOS: CARING FOR A WOMAN OVER HER LIFETIME
Course PG14 (Sunday)
Developed in Cooperation with the Society for Reproductive Endocrinology and Infertility
FACULTY
Kurt T. Barnhart, M.D., M.S.C.E., Chair
University of Pennsylvania
Heather G. Huddleston, M.D.
University of California, San Francisco
Robert A. Wild, M.D., Ph.D., M.P.H.
Oklahoma University Health Sciences Center
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females of reproductive age and is highly prevalent.
The etiology of this heterogeneous condition remains obscure and its phenotype expression varies. PCOS affects many aspects of
a woman’s life and this live course will supply the reproductive endocrinologist and general gynecologist with the latest information
on PCOS in order to provide up-to-date recommendations for patient care. Topics to be covered will include how PCOS affects
reproductive health over a woman’s lifespan, hirsutism and acne, contraception, fertility, menstrual cycle abnormalities, quality of life,
ethnicity, pregnancy complications, long-term metabolic and cardiovascular health and, finally, cancer risk. Information will include
material from The Consensus on Women’s Health Aspects of Polycystic Ovary Syndrome.
ACGME Competency
Practice-based learning and improvement
LEARNING OBJECTIVES
1. Contrast the signs and symptoms of PCOS in women of different ages and ethnicities.
2. Interpret how aspects of the phenotype of PCOS correlate with risk factors for insulin resistance, diabetes mellitus (DM) type II and
26
cardiovascular health.
3. Develop a practical approach to testing for precursors of DM and cardiovascular disease in women with PCOS.
4. Distinguish the medical and reproductive needs of a women with PCOS based on where she is in her lifetime.
BRIDGING THE GAP BETWEEN SCIENCE AND CLINICAL CARE IN ENDOMETRIOSIS-RELATED INFERTILITY
Developed in Cooperation with the Endometriosis Special Interest Group
FACULTY
Hugh S. Taylor, M.D., Chair
Yale University School of Medicine
Thomas M. D’Hooghe, M.D., Ph.D.
Leuven University Hospital
Bruce A. Lessey, M.D., Ph.D.
Greenville Hospital System
Endometriosis is a highly prevalent disease. However, there are many gaps in physicians’ competence to diagnose patients with
endometriosis. This disease places a tremendous burden on society, both economically and related to quality of life. The principal
manifestations of this disease, which causes both infertility and chronic pain, mandate that all general gynecologists and subspecialists
be involved in the care of these patients. This live course is designed to improve physicians’ competence in the medical and surgical
management of endometriosis. Topics to be discussed include: pathophysiology of endometriosis-associated pain syndromes;
pathophysiology of endometriosis-associated infertility; choosing an appropriate medical or surgical therapy; technical aspects of
surgical approaches; in vitro fertilization (IVF) approaches, including pre-IVF optimization; and new genetic etiologies of endometriosis.
Coherent summaries with key learning points will be provided and reinforced during the session of case reports.
ACGME Competency
Patient care

LEARNING OBJECTIVES
1. Discuss clinical implications of the pathophysiology of endometriosis in patients with infertility.
2. Explain the new genetic etiologies for endometriosis and ways to identify those at risk.
3. Describe the options for managing endometriosis before an IVF cycle.
4. Summarize the optimal approach for an IVF cycle in a woman with endometriosis.
LEIOMYOMATA: CLINICAL UPDATES, RESEARCH DEVELOPMENTS
AND DISPARITIES IN DISEASE, OUTCOMES AND ACCESS TO CARE
Developed in Cooperation with the Fibroid Special Interest Group and the Health Disparities Special Interest Group
FACULTY
Gloria Richard-Davis, M.D., Chair
University of Arkansas Medical Sciences
Ayman Al-Hendy, M.D., Ph.D., Co-Chair
Meharry Medical College
Donna Baird, Ph.D.
National Institute of Environmental Health Services (NIEHS)
James H. Segars, M.D.
National Institute of Health (NIH)
Uterine leiomyomata (fibroids), benign estrogen-dependent tumors of the uterine wall, are a common cause of acute and chronic pelvic
pain in women. Uterine fibroids affect 40-80% of women of reproductive age and are the leading indication for hysterectomy in African-
American women. More than 600,000 hysterectomies were done in the United States in 2000 because of leiomyomata. At a mean
cost of $8 billion per year, African-American women are particularly affected as the prevalence of uterine fibroids is about three times
higher in that ethnic group compared with Caucasians. Currently there is no effective medical treatment for this common disease, and
the impact of uterine fibroids on fertility remains controversial. Treatment options for the management of fibroids have largely focused
on surgical options with few focusing on reproductive-sparing procedures. Healthcare providers show no agreement on the best
management option, partially because of their lack of current evidence-based knowledge (including the cause), of uterine fibroids. This
live course, designed for gynecologists, will provide a clear and meaningful overview of the problem, discuss current fibroid treatment
options and their effect on fertility, and probe the future of these treatments.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Explain the developmental origin of uterine fibroids.
2. Describe non-surgical, reproductive-sparing approach for treatment of uterine leiomyomata.
3. Summarize the scientific data on why uterine leiomyomata are more common in African Americans.
4. Discuss the role of myomectomy in the outcomes of assisted reproductive technologies.
CRYOBIOLOGY, CRYOPHYSICS AND QUALITY CONTROL
CONCERNS OF GAMETE, EMBRYO AND TISSUE VITRIFICATION
Developed in Cooperation with the Society of Reproductive Biologists and Technologists
FACULTY
Charles L. Bormann, Ph.D., Chair
Brigham and Women’s Hospital
Wayne A. Caswell, M.S.
Fertility Centers of New England
Joseph Conaghan, Ph.D.
Pacific Fertility Center
Michael J. Tucker, Ph.D.
Shady Grove Fertility RSC
Vitrification (VTF) is rapidly becoming the cryopreservation method of choice for many in vitro fertilization (IVF) laboratories. Without
careful preparation and training, the transition from a slow-rate freeze program to a vitrification program can be very challenging. Most
demonstration and training in VTF techniques have come through workshops sponsored by industry, which may be biased toward
a specific commercial medium and/or storage vessel. However, there are several media and vitrification vessels that can be used
effectively within the IVF laboratory, each with potential strengths and weaknesses. Overview and training with various approaches are
essential, especially with growing concerns over the safety of VTF solutions used, cryo-security, and accepting VTF eggs/embryos in
unfamiliar VTF devices. We are entering a new era of cryobiology where we are faced with serious quality control challenges.
27
ARS

This workshop is geared primarily toward those who would like to implement and optimize VTF in their laboratory. This live course
will provide a solid background in the theories and basic science that has led to the current state of VTF in human systems. We will
demonstrate good tissue practices (GTPs) and discuss quality control concerns. Participants will have an opportunity to train on the
most common commercially available VTF systems being utilized in the United States. Following hands-on experience, each participant
will be able to compare and contrast commonly utilized VTF systems on the market.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Explain the cryobiological/cryophysical principles behind VTF technology via a “hands-on” workshop and contrast VTF and
28
standard slow-freeze preservation.
2. Evaluate, demonstrate, and practice with various commercially available VTF systems and assess the pros and cons in
establishing a VTF program.
3. Describe the steps necessary to implement VTF in their laboratory (training, validation, and quality control).
4. Discuss methods for optimizing and maintaining high success rates with VTF.
EARLY LIFE TOXICANT EXPOSURES AND ADULT REPRODUCTIVE DISORDERS: A POTENTIAL ROLE FOR
NUTRITIONAL INTERVENTION IN BOTH SEXES
Developed in Cooperation with the Environment and Reproduction Special Interest Group and the Nutrition Special Interest Group
FACULTY
Kevin G. Osteen, Ph.D., H.C.L.D., Chair
Vanderbilt University Medical Center
Kaylon L. Bruner-Tran, Ph.D.
Vanderbilt University Medical Center
Antoni J. Duleba, M.D.
University of California, San Diego
Fetal programming is a normal component of developmental processes leading to appropriate organ system function in adults.
However, early life programming processes can be negatively impacted by various environmental factors, including maternal stress,
poor nutrition and exposure to various toxicants. Emerging evidence implies that disruption of fetal and neonatal programming may
significantly affect an individual’s risk of adult disease, including reproductive failure. This concept, known as Developmental Origins
of Health and Disease (DOHaD), requires clinical providers of reproductive medicine to examine the potential role of fetal/neonatal
programming on adult pathology affecting fertility.
This live course will present experimental evidence and clinical observations linking developmental toxicant exposure to reproductive
disorders. Additionally, the faculty will discuss the significance of epigenetic programming on the heritability of toxicant-associated
disorders and will describe the influence of nutrition on reducing the impact of a previous toxicant exposure. Finally, this course will
present the emerging evidence that environmental toxicant exposure of animals and humans impacts adult reproductive function for
multiple generations and will provide specific recommendations for providers to optimize patient care in fertility clinics.
ACGME Competency
Medical knowledge
LEARNING OBJECTIVES
1. Evaluate the evidence implicating environmental toxicant exposure at different stages of life to disruption of adult reproductive tract
function and development of disease.
2. List specific toxicants, their routes of exposure, and mechanisms of action that may negatively impact reproductive processes in
humans.
3. Describe the DOHaD hypothesis and its relevance to reproductive medicine.
4. Discuss how nutrition may modify the negative impact of a prior toxicant exposure and improve reproductive outcomes.
5. Develop improved strategies for ascertaining a couple’s exposure history relevant to infertility treatment.

ULTRASOUND IMAGING IN REPRODUCTIVE MEDICINE: A PRACTICAL APPROACH
Developed in Collaboration with the American Institute of Ultrasound in Medicine
FACULTY
Ilan Tur-Kaspa, M.D., Chair
Institute for Human Reproduction
Beryl R. Benacerraf, M.D.
Harvard Medical School
Steven Goldstein, M.D.
NYU School of Medicine
Elizabeth Puscheck, M.D.
Wayne State Medical Center
Ultrasound and ultrasound-guided procedures have become integral components, not just of assisted reproductive technology (ART),
but also in the day-to-day practice of reproductive medicine, infertility and gynecology. In 2009, new practice guidelines for ultrasound
in reproductive medicine were published by the American Institute of Ultrasound in Medicine (AIUM) and in collaboration with the
American Society for Reproductive Medicine (ASRM). Surveys of members of the Society for Reproductive Endocrinology and Infertility,
the Imaging Special Interest Group and ASRM have revealed a strong desire for CME credits in ultrasonography that would prepare
reproductive medicine professionals and gynecologists for accreditation by the AIUM. In addition, there is an interest in training and
credentialing reproductive nurses and nurse practitioners to perform limited ultrasounds in the office.
The objective of this course is to provide comprehensive survey of the use of ultrasonography in the female pelvis for physicians and
other healthcare providers who use gynecologic ultrasonography. A practical problem-solving approach will be implemented with case
presentations. The faculty will critically review the application of ultrasonography to the infertility evaluation, diagnosis, treatments and
complications as a way to maximize ART success. Ultrasound has helped in the early pregnancy evaluation and monitoring as well as
in assessing pregnancy complications. Many other gynecologic findings on ultrasound such as congenital uterine anomalies, ovarian
masses, tubal disease and other uterine pathologies will be discussed along with their impact on fertility and the decision for surgery.
A variety of reproductive problems throughout the reproductive lifespan, from puberty through menopause, will be addressed from an
ultrasound perspective. Newer technologies with current or potential applications, such as 3-dimensional (3-D) ultrasound, Doppler,
and cost-effective use of CT- and MRI-guided procedures will also be covered. There will be interactive discussion of cases and
controversies, and participants will also have the opportunity to learn practical applications and manipulate 3-D images. This course will
fulfill CME requirements for AIUM credentialing.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Summarize the appropriate use of ultrasonography in the evaluation of infertility, uterine abnormalities and the pathology of the
29
reproductive tract.
2. Describe the proper assessment of early pregnancy and list findings on early pregnancy assessments that are associated with
poor outcome.
3. Discuss the importance of 3-D ultrasonography in reproductive medicine, and the importance of Doppler blood flow assessment in
reproductive medicine and gynecology.
4. Evaluate patients with pelvic pain, abnormal bleeding and adnexal masses using a practical approach.
5. Evaluate when surgical intervention is needed, when cancer is suspected and when imaging procedures can be performed to treat
abnormalities on ultrasound.

GLOBAL FAMILY PLANNING: THE KEY TO ACHIEVING MILLENNIUM DEVELOPMENT GOALS
Developed in Cooperation with the Contraception Special Interest Group
FACULTY
Alison Edelman, M.D., M.P.H., Chair
Oregon Health and Science University
Paul Blumenthal, M.D.
Stanford University
Matthew F. Reeves, M.D., M.P.H.
WomanCare Global
Unintended pregnancies continue to be at epidemic levels in the United States and worldwide. Unsafe abortion continues to be one of
the top killers of women worldwide. The use of long-acting, reversible and permanent contraceptive methods prevent both pregnancies
and abortions. One important barrier to contraceptive use is lack of knowledge and hands-on experience among healthcare providers
on “best practices” for contraceptive care. In addition, providers lack the skills for safe abortion care including postabortion and
miscarriage management.
The Contraception Special Interest Group determined that a postgraduate course with a hands-on component would benefit
reproductive endocrinologists, general obstetrician-gynecologists, general internists, family medicine providers, and nurse practitioners.
The topics to be covered in this live course include: achieving millennium development goals (MDG) in the current world situation;
family planning and the environment; postpartum/postabortion contraception; transcervical and minilaparotomy sterilization; natural
family planning; medical management of spontaneous abortions, postabortion care, and safe abortion care; manual vacuum aspiration
(MVA) from biopsies, retained placentas, to abortions; resources for the clinician; medical eligibility criteria from the World Health
Organization and the Centers for Disease Control; and novel, developing contraception methods. The hands-on component will
allow participants to improve clinical skills in postpartum/postabortion intrauterine device (ppIUD) insertion, Essure®/Adiana®, MVA,
transcervical and minilaparotomy permanent contraception, and dilatation and evacuation.
ACGME Competency
Medical knowledge
LEARNING OBJECTIVES
1. Analyze the current world situation, MDG goals and environmental issues related to population and family planning and
recommend resources that aid the clinician in the provision of contraceptive care.
2. Explain family-planning methods with the greatest impact for reducing maternal morbidity and mortality (use of ppIUD, permanent
30
contraception, and novel methods being developed).
3. Apply the acquired skills to perform ppIUD insertion and transcervical and minilaparotomy permanent contraception.
4. Describe safe and standardized regimens for the medical management of incomplete abortion, miscarriage or undesired
pregnancy.
5. Describe and demonstrate the use of manual vacuum aspirator for gynecologic, obstetric and family planning indications.
OPTIMIZING THE SAFETY OF IN VITRO FERTILIZATION
ARS
Developed in Cooperation with the Society for Assisted Reproductive Technology
FACULTY
Valerie L. Baker, M.D., Chair
Stanford University Medical Center
Anja Pinborg, M.D.
University of Copenhagen
Catherine Racowsky, Ph.D.
Brigham and Women’s Hospital and Harvard Medical School
Although assisted reproductive technology (ART) is a widely-used treatment that often leads to the birth of healthy children without
serious maternal complications, concerns have been raised about increased risk of certain adverse outcomes for both the mother and
the offspring. ART has been associated with higher rates of compromised fetal growth, preterm delivery, maternal complications such as
preeclampsia, and possibly congenital anomalies and epigenetic disorders. Some risks of adverse outcomes associated with ART are
likely attributable to the underlying infertility. However, it is important for clinicians to be aware of ART risks that may be associated with
the treatment itself. Some adverse outcomes associated with ART may be attributable to multiple gestation, laboratory practices, or the
unphysiologic maternal state in which pregnancy typically begins with ART.
This live course will equip clinicians to better inform patients about the risks and benefits of various aspects of ART. Faculty will
provide recommendations on how to mitigate the risks, including optimization of ovulation induction, and maximize the safety of ART.
Other topics covered include an up-to-date understanding of the benefits and risks of various laboratory procedures and ART treatment
for patients with medical problems.

ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Choose individualized ovulation stimulation protocols with consideration given to both potential short-term and long-term
31
consequences for the mother and fetus.
2. Explain the risks and benefits of laboratory practices such as extended culture, embryo biopsy at different stages, oocyte
cryopreservation and open versus closed vitrification.
3. Provide recommendations that will reduce the risk of multiple gestation while still maintaining a high live-birth rate.
4. Advise patients at increased risk of pregnancy complications.
THE SIGNIFICANCE, IMPLICATIONS AND HERITABILITY OF MALE INFERTILITY AS A DISEASE
ARS
Developed in Cooperation with the Society for Male Reproduction and Urology
FACULTY
Paul J. Turek, M.D., Chair
The Turek Clinic
Douglas T. Carrell, Ph.D., H.C.L.D.
University of Utah School of Medicine
Andrea Salonia, M.D.
University Vita-Salute San Raffaele
Thomas J. Walsh, M.D., M.S.
University of Washington School of Medicine
The clinical significance of the male factor infertility evaluation has been underestimated to date. Given the well-described associations
between male infertility and a) underlying concurrent medical conditions, b) genetic anomalies, c) environmental exposures and d)
future cancers, male factor infertility is clearly a disease of clinical and epidemiological significance. However, it is estimated that less
than one in four infertile males in the United States receives the recommended male factor evaluation as part of the couple infertility
assessment. Educating clinicians about the implications of male factor infertility is the first step in changing clinical behavior that
incorporates the male factor evaluation into every couple’s assessment.
Through a thorough discussion of our current understanding of the medical, genetic and epidemiologic issues associated with male
factor infertility, this course seeks to raise awareness and change practice patterns of clinicians who care for infertile couples. By
emphasizing that male infertility is a window into both current and future health of the individual (i.e., is a biomarker of health), this
course will: improve clinicians’ level of understanding and knowledge of relevant lifestyle issues and behaviors that are associated
with infertility, help clinicians precisely identify those individuals at risk for genetic infertility, and enable clinicians to better educate their
patients regarding the health risks associated with a male infertility diagnosis. It is our hope that this course will enlighten clinicians,
laboratory technicians and researchers alike of the full impact of male infertility on the health, quality of life and longevity of affected
individuals.
ACGME Competency
Patient care
LEARNING OBJECTIVES
1. Describe three metabolic or hormonal disorders that are associated with male factor infertility.
2. List the clinical criteria that define men at risk for genetic infertility due to Y chromosome deletions or karyotype anomalies.
3. Delineate four lifestyle, occupational or exposure risk factors linked to male factor infertility.
4. List two cancers that are more likely to occur in infertile men than otherwise healthy men AFTER a diagnosis of male factor
infertility.
5. Explain two genetic or medical conditions in offspring that are associated with severe male factor infertility or older paternal age.

TRAINING PEOPLE IN LOW-COST INFERTILITY AND ART TREATMENT
Developed in Cooperation with the International Federation of Fertility Societies
FACULTY
Ian D. Cooke, M.B., FRCOG, F.Med.Sci., Chair
University of Sheffield
Luca Gianaroli, M.D.
S.I.S.Me.R.
M. Cristina Magli, Ph.D.
S.I.S.Me.R.
Pasquale Patrizio, M.D., M.B.E.
Yale University
Access to infertility diagnosis and treatment is extremely poor in the developing world. There are too few clinics or private doctors
interested in and competent to manage infertility problems, no adequate referral systems, and few trained staff. National health services
provide few treatments as many countries struggle with major disease, such as human immunodeficiency virus (HIV), malaria and
tuberculosis (TB). Available private services are usually too costly for the average patient and can result in catastrophic expense. The
most common cause of infertility in developing nations is tubal obstruction from infection, either chlamydia, gonorrhea or postpartum
or postabortion sepsis, where the only realistic management plan includes in vitro fertilization (IVF). However, public health education
on reproduction is minimal and infertility is surrounded by fear and superstition and compounded by local religious attitudes. Treatment
options are not widely known and sophisticated methods, such as assisted reproductive technology (ART), are not available.
Management of infertility needs to be conducted within a framework of adequate reproductive health services, so that preparation
for pregnancy, the pregnancy and the delivery are competently managed, in places where skilled attendance at delivery may not be
standard practice. Health professionals, either nationals of low resource economies or altruistic academics from developed countries,
wanting to implement infertility treatments and ART in the developing world must understand the problems and acquire the competence
to approach them in ways that are cost-effective for their region and not simply attempt to transfer systems developed for more-affluent
environments.
This live course will describe how to develop assisted-conception services in low-resource environments. Discussion will cover how
to find suitable laboratory space, provide robust equipment and maintain it in working order, maintain lab records with a view to quality
control, trouble shoot, and use the laboratory data to develop the service. Identifying potential patients, patient screening, meeting with
both partners, and treatment prior to ART will be emphasized as well as the principles of preparation for pregnancy and obstetric care.
The indications for intra-uterine insemination (IUI) and IVF (and the need for intra-cytoplasmic sperm injection [ICSI]) will be elaborated
in the context of education about reproductive biology, pathology and specific treatment for the couple and the implications for public
health education. Minimal ovarian stimulation will be discussed in the context of avoiding hyperstimulation and multifetal pregnancy. The
critical role of ultrasound will be presented with technical details of appropriate apparatus and the skill requirements and methods for
acquiring them will be presented. The role of various staff members will be elaborated and include quality standards.
Finally, an appraisal of the financial viability of developing an assisted-conception clinic and the use of data obtained from such a
clinic will be detailed. Data can be reported to national and international registries and used to attract patients and influence policy
related to service provision at a national level, thus helping to extend local health service to a greater proportion of the population in
accordance with the World Health Organization rubric of appropriately-stratified healthcare.
ACGME Competency
LEARNING OBJECTIVES
1. Explain the rationale for providing assisted-conception services in low-resource environments.
2. Develop a clinic offering suitable ART services and competently manage patients in such a setting.
3. Specify the steps required for financial viability and for quality data retention and reporting.
4. Develop educational programs suitable for patients, the general public and health service administrators.
32

Transforming Reproductive Medicine Worldwide Conference 2013

Transforming Reproductive Medicine Worldwide Conference 2013

Recomendados

Recomendados

Más contenido relacionado

Similar a Transforming Reproductive Medicine Worldwide Conference 2013

Similar a Transforming Reproductive Medicine Worldwide Conference 2013 (20)

Más de 鋒博蔡

Más de 鋒博蔡 (20)